Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Liberale

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
Cardiovascular Research|August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammationLuca Liberale, Simon Kraler, Yustina M Puspitasari, et al.
European Journal of Clinical Investigation|January 24, 2024
Osteopontin is associated with neutrophil extracellular trap formation in elderly patients with severe sepsisMaria Bertolotto, Daniela Verzola, Paola Contini, et al.
International Journal of Cardiology|April 7, 2018
Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injuryCandela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Cardiovascular Research|September 15, 2020
Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic systemLuca Liberale, Alexander Akhmedov, Nikolaos I Vlachogiannis, et al.
European Heart Journal|May 14, 2022
Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromesSimon Kraler, Florian A Wenzl, Georgios Georgiopoulos, et al.
European Journal of Internal Medicine|July 17, 2024
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patientsLuca Liberale, Claudia Torino, Patrizia Pizzini, et al.
Biomedicines|November 27, 2024
Osteopontin and Clinical Outcomes in Hemodialysis PatientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
International Journal of Cardiology|July 16, 2018
Corrigendum to 'Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury' [Int. J. Cardiol. 260 (2018) 148-155]Candela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
European Journal of Clinical Investigation|May 11, 2024
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 7, 2024
Osteopontin, death and cardiovascular events in stage G3-4 CKD patients: a joint model analysisGraziella D'Arrigo, Federico Carbone, Mercedes Gori, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Cardiovascular Research|August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammationLuca Liberale, Simon Kraler, Yustina M Puspitasari, et al.
European Journal of Clinical Investigation|January 24, 2024
Osteopontin is associated with neutrophil extracellular trap formation in elderly patients with severe sepsisMaria Bertolotto, Daniela Verzola, Paola Contini, et al.
International Journal of Cardiology|April 7, 2018
Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injuryCandela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Cardiovascular Research|September 15, 2020
Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic systemLuca Liberale, Alexander Akhmedov, Nikolaos I Vlachogiannis, et al.
European Heart Journal|May 14, 2022
Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromesSimon Kraler, Florian A Wenzl, Georgios Georgiopoulos, et al.
European Journal of Internal Medicine|July 17, 2024
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patientsLuca Liberale, Claudia Torino, Patrizia Pizzini, et al.
Biomedicines|November 27, 2024
Osteopontin and Clinical Outcomes in Hemodialysis PatientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
International Journal of Cardiology|July 16, 2018
Corrigendum to 'Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury' [Int. J. Cardiol. 260 (2018) 148-155]Candela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
European Journal of Clinical Investigation|May 11, 2024
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patientsClaudia Torino, Federico Carbone, Patrizia Pizzini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 7, 2024
Osteopontin, death and cardiovascular events in stage G3-4 CKD patients: a joint model analysisGraziella D'Arrigo, Federico Carbone, Mercedes Gori, et al.
Pageof 20